About us

Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a family-owned and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our customers.

Founded in 2008, Coriolis is the expert in formulation development for liquid drugs, formulation and process development for freeze-dried products, well as analytical services including GMP (Good Manufacturing Practice) and legitimate release analysis.

We have supported the successful development of many drug products and formulations, and our scientists are eager to apply their experience on a large range of molecules (including proteins, peptides, monoclonal antibodies, RNA/DNA carrier systems, virus-like particles, viruses, bacteria and vaccines) to your project.

Our facts & figures

#
years_experience
10+
years of experience in biopharma development
#
qualified_employees
115+
highly qualified employees
#
analytical_methods
90+
different analytical methods in house
#
laboratory
2000 m²
lab space incl. BSL-1/BSL-2 & GMP
#
peer_reviewed
44+
peer reviewed scientific publications
#
global_customers
600+
global customers from start-up to Big Pharma
#
projects_performed
1100+
projects performed successfully

Our milestones

our_approach
2008

Foundation of Coriolis Pharma

working_at_coriolis
2009

Move to the IZB (Innovation and Start-Up Center for Biotechnology) in Martinsried

gmp_analysis
2012

GMP accreditation

bio_safety_level
2016/17

Biological Safety Level (BSL) 1 & 2 certification

laboratory
2017

Move to new facilities in Martinsried

years_experience
2018

10th anniversary of Coriolis Pharma